Intellectual Property India Publishes Patent Application for 'Methods For Creating Regulatory T Cells (TREGS) Using Genome Engineering' Filed by Lung Biotechnology Pbc

MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202517099221 A) filed by Lung Biotechnology Pbc, Maryland, U.S.A., on Oct. 14, for 'methods for creating regulatory t cells (tregs) using genome engineering.'

Inventor(s) include Exline, Colin; Wong, Kurt; Stevens, Sean; and Liu, Huizhu.

The application for the patent was published on Nov. 21, under issue no. 47/2025.

According to the abstract released by the Intellectual Property India: "Provided are methods, polynucleotides and compositions for the generation of engineered Treg cells. The methods, polynucleotides and compositions enable the reprogramming of hematopoietic cells into Treg cells by constitutive or regulated expression of FOXP3 in engineered cells such that the engineered Treg cells can suppress the activation and proliferation of responder T cells."

The patent application was internationally filed on Mar. 20, 2024, under International application No.PCT/US2024/020761.

Disclaimer: Curated by HT Syndication.